200 related articles for article (PubMed ID: 38058831)
1. Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients.
Huang W; Hu Y; Zhang X; Xu Y; Sun Z; Ding P; Qian X; Ali A; Chen Z
Am J Cancer Res; 2023; 13(11):5531-5548. PubMed ID: 38058831
[TBL] [Abstract][Full Text] [Related]
2. Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry.
Li J; Ramzan F; Zhong G
Am J Cancer Res; 2023; 13(9):4376-4400. PubMed ID: 37818076
[TBL] [Abstract][Full Text] [Related]
3. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
[TBL] [Abstract][Full Text] [Related]
4. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract][Full Text] [Related]
6. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
Sun X; Chen Q; Zhang L; Chen J; Zhang X
Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension.
Yang T; Li ZN; Chen G; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; Xiong CM; He JG
Heart Lung; 2014; 43(4):322-7. PubMed ID: 24856224
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and prognostic value of C-X-C motif chemokine ligand 1 in colon adenocarcinoma based on The Cancer Genome Atlas and Guangxi cohort.
Gong YZ; Ma H; Ruan GT; Zhu LC; Liao XW; Wang S; Yan L; Huang W; Huang KT; Xie H; Zhu GZ; Wang XK; Liao C; Gao F
J Cancer; 2021; 12(18):5506-5518. PubMed ID: 34405013
[No Abstract] [Full Text] [Related]
9. CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates.
Darakhshan S; Hassanshahi G; Mofidifar Z; Soltani B; Karimabad MN
Pregnancy Hypertens; 2019 Jul; 17():36-42. PubMed ID: 31487653
[TBL] [Abstract][Full Text] [Related]
10. Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Zhang L; Jiang X; Li Y; Fan Q; Li H; Jin L; Li L; Jin Y; Zhang T; Mao Y; Hua D
Front Oncol; 2020; 10():1504. PubMed ID: 32983993
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of
Shi C; Xie LY; Tang YP; Long L; Li JL; Hu BL; Li KZ
Front Genet; 2019; 10():1097. PubMed ID: 31781164
[No Abstract] [Full Text] [Related]
12. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated and hypomethylated genes are causative factors and diagnostic markers of osteoporosis.
Minbo J; Feng C; Wen H; Jamil M; Zhang H; Abdel-Maksoud MA; Zakri AM; Almanaa TN; Alfuraydi AA; Almunqedhi BM
Am J Transl Res; 2023; 15(10):6042-6057. PubMed ID: 37969207
[TBL] [Abstract][Full Text] [Related]
14. Identification of hub genes and functional modules in colon adenocarcinoma based on public databases by bioinformatics analysis.
Zhang Z; Luo A; Zeng Z; Zhou Y; Wu W
J Gastrointest Oncol; 2021 Aug; 12(4):1613-1624. PubMed ID: 34532115
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
Front Oncol; 2021; 11():711402. PubMed ID: 34497764
[TBL] [Abstract][Full Text] [Related]
16. Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Zhang X; Gao F; Li N; Zhang J; Dai L; Yang H
J Cancer; 2020; 11(11):3124-3143. PubMed ID: 32231717
[No Abstract] [Full Text] [Related]
17. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells.
Hieshima K; Kawasaki Y; Hanamoto H; Nakayama T; Nagakubo D; Kanamaru A; Yoshie O
J Immunol; 2004 Sep; 173(6):3668-75. PubMed ID: 15356112
[TBL] [Abstract][Full Text] [Related]
18. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
[TBL] [Abstract][Full Text] [Related]
20. The role of CXCL10 in prognosis of patients with colon cancer and tumor microenvironment remodeling.
Song W; Yin H; Han C; Mao Q; Tang J; Ji Z; Yan X; Wang L; Liu S; Ai C
Medicine (Baltimore); 2021 Sep; 100(38):e27224. PubMed ID: 34559115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
